GPCR

Structure Therapeutics INC

-$1.4B

Net Activity

Institutions Holding

197

Popularity Rank

#2926

Avg Weight

0.33%

Total Value

$3.3B

Ownership Trend

197 institutions currently hold GPCR, with 110 net buyers and 97 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

97

Net Buying Institutions

110

Key Holders

View all 197 holding institutions

Quarterly Activity

Recent Activity

+$1.8B

Total Buy Value

$1.7B

Total Sell Value

New buy37
Trim61
Add73
Sold out36

110

Net Buyers

97

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$1.71M

Total Est. Value

36K shares

Planned Shares

Last Filed 2026-06-25
FilerFiling DateEst. Value
Lin Xichen2026-06-25$1.71M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding STRUCTURE THERAPEUTICS INC (GPCR)?
Major stakeholders currently include FMR LLC ($405.0M), Wellington Management Group LLP ($349.9M), Avoro Capital Advisors LLC ($316.0M). Based on the latest 13F filings, there are a total of 197 tracked investment funds and institutions maintaining positions in GPCR.
What is the overall institutional sentiment toward GPCR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.4B, driven by 110 managers accumulating shares while 97 reduced their exposure.
Which institutions have been selling or reducing their GPCR positions?
In the latest period, 61 funds trimmed their holdings, and 36 managers completely exited their positions. The aggregate reported sell value was $1.7B.
Are there any notable investors adding GPCR to their portfolios?
Yes, buying activity remains notable. 37 institutions opened new positions in {ticker}, and 73 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.8B.

Related Stocks